They found that the autocrine PD-L1 scFv antibody reduced the expression of exhaustion markers PD-1, TIM-3, and CTLA-4 in an in vivo tumor model, thus preventing CAR-T cell exhaustion [122]. This evidence concerns the gene CD274 and neoplasm.